Navigation Links
Five Leading Academic Hospitals Install the CyberKnife System for Dedicated Radiosurgery

SUNNYVALE, Calif., July 25, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today installation of the CyberKnife® Robotic Radiosurgery System at five renowned academic oncology centers in Europe and the United States, including the Penn Medicine at Pennsylvania Hospital in Philadelphia, PA; The Royal Marsden Hospital in London, England; The Barts Cancer Center at St. Bartholomew's Hospital in London, England; Charite University in Berlin, Germany; and Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch in Gliwice, Poland. Backed by solid clinical evidence for a wide range of treatment applications, including prostate and lung cancer, the CyberKnife System empowers these leading centers to offer minimally invasive radiosurgical treatment options for patients with even the most complex tumors.

"Adoption of the CyberKnife System at these prestigious academic medical centers known for offering patients the most innovative and state-of-the-art options for cancer treatment is further validation of CyberKnife as the premier system for dedicated radiosurgery," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray Incorporated. "Accuray is proud to work with a growing number of academic centers around the world that are advancing the use of radiosurgery beyond intracranial applications to treat patients with a wide range of indications and breaking new ground in both research and patient care."

"We chose the CyberKnife System because of the scientific evidence demonstrating the technology's ability to treat a broad range of tumors anywhere in the body. This functionality is simply not possible with other technologies, including hybrid radiation therapy systems," stated Prof. Dr. Volker Budach and Prof. Dr. Peter Vajkoczy, respective heads of the departments of Radiation Oncology and Neurosurgery at Charite University in Berlin "Our mission at Charite is to provide patients with the most personalized care when treating cancer. The CyberKnife System, combined with our physicians' expertise, allows us to better tailor our treatments using the most advanced technology in radiosurgery."

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray's game-changing technologies – the CyberKnife System and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 550 systems have been installed in leading hospitals around the world. For more information, please visit

Safe Harbor Statement

The foregoing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to clinical experience and market acceptance are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: range of treatment options, clinical applications, clinical research and market acceptance of products and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2010 fiscal year, our form 10-Q filed on May 10, 2011 and our other filings with the Securities and Exchange Commission.. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Euan Thomson, Ph.D.

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Question Your Dentist About Potential for Cross-Contamination, Leading Infection-Control Scientist Tells Fox News
2. Laureate Biopharma to Produce Biosimilar Product for Leading Generics Company
3. Cal/OSHA Fines Prominent Pharmaceutical Firm $371,000 for Safety Violations Leading to Worker Fatality
4. DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting
5. BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline
6. Autonomy Powers Award-Winning Website for Leading Swiss Pharmaceutical Company
7. Texas & U.S. Drug Treatment Gap to Be Highlighted at News Conference 11 a.m. June 23 By Former U.S. Drug Czar, U.S. Music Industry/Grammys Addiction Services Leader, Miss Texas 2007, San Antonio Police Chief, Nations Leading Treatment CEO, Experts
8. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
9. Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China
10. WaferGen Closes $30 Million Financing with Three Leading Life Science Institutional Investors
11. MedClean Technologies Forms Co-Promotion Relationship With Covidien, Leading Global Healthcare Products Manufacturer
Post Your Comments:
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the French ...
(Date:11/26/2015)... November 26, 2015 ... universitetssjukhus ser potential att använda SyMRI för ... för patienter med multipel skleros (MS) ... med SyntheticMR AB för att kunna använda ... sjukhuset. Med SyMRI kan man generera flera ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk based contact center ... reliability. , The new Q-Suite 6 platform is based on the latest Java Enterprise ... a specific piece of software for many key components of the suite. Much of ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... For the ... companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two groups ... to aid in MAP International’s cause. , MAP International was founded in 1954 and ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, the industry ... Wimbledon Athletics Facebook page to educate the public, parents and school athletic ... 2,000 people under the age of 25 die from sudden cardiac arrest every ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
Breaking Medicine News(10 mins):